SUMO‐modified insulin‐like growth factor 1 receptor (IGF‐1R) increases cell cycle progression and cell proliferation
暂无分享,去创建一个
O. Larsson | P. Agarwal | F. Haglund | Yingbo Lin | H. Jernberg-Wiklund | D. Warsito | A. Waraky | Hongyu Liu
[1] O. Larsson,et al. Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein , 2016, Oncotarget.
[2] J. Liao,et al. Growth Modulation of Diabetic Factors and Antidiabetic Drugs on Prostate Cancer Cell Lines. , 2016, The Chinese journal of physiology.
[3] C. Pellegrini. New therapeutic approaches to HGPS based on progerin inhibition , 2015, Orphanet Journal of Rare Diseases.
[4] D. Yee,et al. Minireview: Were the IGF Signaling Inhibitors All Bad? , 2015, Molecular endocrinology.
[5] Jian Zhang,et al. SUMOylation of insulin-like growth factor 1 receptor, promotes proliferation in acute myeloid leukemia. , 2015, Cancer letters.
[6] S. Ferrari,et al. Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? , 2015, Orphanet Journal of Rare Diseases.
[7] O. Larsson,et al. Nuclear translocation of IGF-1R via p150Glued and an importin-β/RanBP2-dependent pathway in cancer cells , 2014, Oncogene.
[8] J. A. van der Laak,et al. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice. , 2013, European journal of cancer.
[9] C. Keller,et al. Dynamic and Nuclear Expression of PDGFRα and IGF-1R in Alveolar Rhabdomyosarcoma , 2013, Molecular Cancer Research.
[10] J. Blay,et al. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas. , 2012, European journal of cancer.
[11] O. Larsson,et al. Nuclear IGF1R is a transcriptional co‐activator of LEF1/TCF , 2012, EMBO reports.
[12] N. Shomron,et al. Insulin-like Growth Factor-I Receptor (IGF-IR) Translocates to Nucleus and Autoregulates IGF-IR Gene Expression in Breast Cancer Cells , 2011, The Journal of Biological Chemistry.
[13] O. Larsson,et al. Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. , 2011, Biochemical and biophysical research communications.
[14] M. Howarth,et al. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. , 2010, Cancer research.
[15] M. Carreira,et al. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. , 2010, The Journal of endocrinology.
[16] O. Larsson,et al. SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor , 2010, Science Signaling.
[17] R. Baserga. The insulin receptor substrate-1: a biomarker for cancer? , 2009, Experimental cell research.
[18] D. Clemmons,et al. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer , 2007, Nature Reviews Drug Discovery.
[19] F. Giorgino,et al. The IGF-I signaling pathway. , 2007, Current pharmaceutical design.
[20] R. Baserga,et al. Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA. , 1996, Journal of experimental therapeutics & oncology.
[21] M. Rubini,et al. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.